Welby Inc. (TYO:4438)

Japan flag Japan · Delayed Price · Currency is JPY
308.00
+13.00 (4.41%)
Apr 28, 2026, 3:30 PM JST
Market Cap2.55B -2.5%
Revenue (ttm)635.00M +20.3%
Net Income-539.00M
EPS-65.13
Shares Out8.28M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume19,800
Average Volume22,540
Open297.00
Previous Close295.00
Day's Range297.00 - 313.00
52-Week Range276.00 - 558.00
Beta1.24
RSI43.35
Earnings DateMay 11, 2026

About Welby

Welby Inc. engages in the provision of digital health solutions that help patients to get medical care services in Japan. The company provides services in the areas of diabetes, lifestyle-related disease, autoimmune disease, rare disease, oncology, and blood disorders. It also engages in the medical data research business; and operates apps, web services, and data management. Welby Inc. was incorporated in 2011 and is headquartered in Chuo, Japan. [Read more]

Industry Medical - Healthcare Information Services
Sector Healthcare
Founded 2011
Employees 44
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4438
Full Company Profile

Financial Performance

In 2025, Welby's revenue was 635.00 million, an increase of 20.27% compared to the previous year's 528.00 million. Losses were -539.00 million, -32.96% less than in 2024.

Financial Statements